Interestingly, studies using genetic approaches showed that DPYSL3 levels were inversely altered with changes in MYCN expression, thus suggesting a MYCN negative regulation of DPYSL3 in NB cells, probably via EZH2. Here, DPYSL3 is linked to neuroblastoma.